Angiotensin Receptor Blockers as an Alternative to Angiotensin-Converting Enzyme Inhibitors in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention

BACKGROUND: Angiotensin-converting enzyme inhibitors (ACEIs) are the first choice for the treatment of acute myocardial infarction (AMI), and angiotensin receptor blockers (ARBs) should be considered in patients intolerant to ACEIs. Although previous studies support the use of ARBs as an alternative...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Korean Med Sci
Main Authors: Lim, Sungmin, Choo, Eun Ho, Choi, Ik Jun, Ihm, Sang-Hyun, Kim, Hee-Yeol, Ahn, Youngkeun, Chang, Kiyuk, Jeong, Myung Ho, Seung, Ki-Bae
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Academy of Medical Sciences 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6875434/
https://ncbi.nlm.nih.gov/pubmed/31760711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2019.34.e289
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados